Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03410823
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-06-26
First Post:
2017-12-07
Brief Title:
PUSH Plus Protein Pilot for Hip Fracture Patients
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
Community Ambulation Project CAP Ancillary Study - PUSH Plus Protein Pilot Study
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hip fracture is a common problem among older individuals The goal of current standard of care after hip fracture is to achieve independent household ambulation 2-3 months after surgery yet decreased functional ability typically persists well beyond three months and many patients never resume independent ambulation outside the home Previous research has established that one must be able to walk at least 300 meters 330 yards within 6 minutes to re-establish routine interactions in the community such as going to the store or to church In part this is based on the average distance from handicapped parking spaces into most facilities Activity and exercise are believed to be of benefit for reducing disability in older adults yet the majority of older adults does not participate in regular exercise and is not active This is especially true for older adults following hip fracture after they complete the usual rehabilitation program
This research study is being done to test a 16-week multi-part exercise intervention for hip fracture patients that will be supervised by specially trained physical therapists PTs The exercise intervention uses a novel machine to provide strength and endurance training in the home This has been shown in smaller studies to be safe and effective at increasing strength The purpose of this small pilot study is to test whether adding a protein supplement to the exercise intervention leads to more improvements in a persons ability to walk in their own home and in the local community With this knowledge investigators hope to help a greater number of hip fracture patients enjoy a more complete recovery and improved overall health
In addition to providing important information on adherence feasibility and safety this pilot study of hip fracture patients has the unique advantage of being able to compare data to two recently completed studies where participants received the PUSH intervention without protein supplementation
This research study is being done to test a 16-week multi-part exercise intervention for hip fracture patients that will be supervised by specially trained physical therapists PTs The exercise intervention uses a novel machine to provide strength and endurance training in the home This has been shown in smaller studies to be safe and effective at increasing strength The purpose of this small pilot study is to test whether adding a protein supplement to the exercise intervention leads to more improvements in a persons ability to walk in their own home and in the local community With this knowledge investigators hope to help a greater number of hip fracture patients enjoy a more complete recovery and improved overall health
In addition to providing important information on adherence feasibility and safety this pilot study of hip fracture patients has the unique advantage of being able to compare data to two recently completed studies where participants received the PUSH intervention without protein supplementation
Detailed Description:
A pilot study including 30 older adults who have experienced a hip fracture will be carried out with participants receiving a specific multi-component intervention with protein supplementation PUSH Plus Protein Study activities for participants meeting eligibility criteria will take place after post-acute rehabilitation ends up to 26 weeks after admission to the hospital for hip fracture Patients age 60 and older who have had surgical repair for hip fracture will be identified in study hospitals or by self-referral and evaluated for eligibility Following consent to participate eligible participants will undergo a comprehensive baseline assessment Participants completing the entire baseline assessment will be eligible to receive the intervention All participants will receive the PUSH Plus Protein intervention The follow-up assessment will occur after the intervention is completed approximately 16 weeks after baseline testing The primary endpoint will be measured using the Six-Minute Walk Test SMWT
Participants in this pilot will receive the same specific multi-component 16-week intervention PUSH as participants in the multi-site randomized controlled trial Improving Community Ambulation after Hip Fracture CAP NCT01783704 The purpose of this study is to test whether adding a protein supplement to the PUSH intervention PUSH Plus Protein leads to greater improvement in a persons ability to walk in their own home and in the local community compared to the PUSH intervention alone therefore data in this pilot study will be compared to data from participants in the CAP study across the three sites who received the PUSH intervention alone n105 The working hypothesis is that PUSH Plus Protein will lead to greater improvements in ability to walk in the community compared to PUSH
Investigators will also compare the effect of PUSH Plus Protein intervention to PUSH intervention alone on secondary outcomes in the CAP study believed to be precursors to community ambulation as shown in Aim 2 below
Investigators can also compare participants in the pilot study to participants who received PUSH alone in the ancillary study to CAP Mechanistic Pathways to Community Ambulation CAP-MP n19 to examine whether PUSH Plus Protein has an impact on the mechanistic factors on the pathway to recovery of ambulatory ability after hip fracture Aim 3
Aim 1 To test whether PUSH Plus Protein intervention improves community ambulation as measured by distance walked in six minutes compared to PUSH intervention alone from CAP parent study at the end of 16 weeks
Aim 2 To assess the effects of PUSH Plus Protein on precursors to community ambulation compared to the PUSH intervention alone CAP study To determine the effects of PUSH Plus Protein intervention compared to PUSH on several other outcomes in CAP including activities of daily living ADLs quality of life lower-extremity physical performance increase of 50 meters in distance walked in six minutes cognitive status and nutritional status
Aim 3 To determine the effects of PUSH Plus Protein intervention on the mechanistic factors compared to PUSH intervention alone CAP-MP ancillary study To determine if at the end of the 16 week intervention participants in the PUSH Plus Protein intervention compared to PUSH alone have a greater muscle volume and attenuation ie reduced intra-muscular fat of the thigh b greater lower extremity strength c better gait parameters d greater bone mineral density and bone strength e more bone formation and less bone resorption and f lower levels of circulating inflammatory cytokines
Aim 4 To determine safety and tolerability of delivering the PUSH Plus Protein intervention to hip fracture patients This pilot study will be used to estimate the sample size requirements for a more definitive study
Participants in this pilot will receive the same specific multi-component 16-week intervention PUSH as participants in the multi-site randomized controlled trial Improving Community Ambulation after Hip Fracture CAP NCT01783704 The purpose of this study is to test whether adding a protein supplement to the PUSH intervention PUSH Plus Protein leads to greater improvement in a persons ability to walk in their own home and in the local community compared to the PUSH intervention alone therefore data in this pilot study will be compared to data from participants in the CAP study across the three sites who received the PUSH intervention alone n105 The working hypothesis is that PUSH Plus Protein will lead to greater improvements in ability to walk in the community compared to PUSH
Investigators will also compare the effect of PUSH Plus Protein intervention to PUSH intervention alone on secondary outcomes in the CAP study believed to be precursors to community ambulation as shown in Aim 2 below
Investigators can also compare participants in the pilot study to participants who received PUSH alone in the ancillary study to CAP Mechanistic Pathways to Community Ambulation CAP-MP n19 to examine whether PUSH Plus Protein has an impact on the mechanistic factors on the pathway to recovery of ambulatory ability after hip fracture Aim 3
Aim 1 To test whether PUSH Plus Protein intervention improves community ambulation as measured by distance walked in six minutes compared to PUSH intervention alone from CAP parent study at the end of 16 weeks
Aim 2 To assess the effects of PUSH Plus Protein on precursors to community ambulation compared to the PUSH intervention alone CAP study To determine the effects of PUSH Plus Protein intervention compared to PUSH on several other outcomes in CAP including activities of daily living ADLs quality of life lower-extremity physical performance increase of 50 meters in distance walked in six minutes cognitive status and nutritional status
Aim 3 To determine the effects of PUSH Plus Protein intervention on the mechanistic factors compared to PUSH intervention alone CAP-MP ancillary study To determine if at the end of the 16 week intervention participants in the PUSH Plus Protein intervention compared to PUSH alone have a greater muscle volume and attenuation ie reduced intra-muscular fat of the thigh b greater lower extremity strength c better gait parameters d greater bone mineral density and bone strength e more bone formation and less bone resorption and f lower levels of circulating inflammatory cytokines
Aim 4 To determine safety and tolerability of delivering the PUSH Plus Protein intervention to hip fracture patients This pilot study will be used to estimate the sample size requirements for a more definitive study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R37AG009901 | NIH | None | httpsreporternihgovquickSearchR37AG009901 |